Abbott Laboratories (ABT) reported that its first-quarter net earnings rose to $1.24 billion or $0.78 per share, from $864 million or $0.55 per share in the same quarter last year.
Excluding Specified Items, net earnings for the quarter were $1.65 billion or $1.03 per share, up from $1.42 billion or $0.91 per share last year. Analysts polled by Thomson Reuters expected the company to report earnings of $1.00 per share. Analysts' estimates typically exclude special items.
Net sales for the quarter rose to $9.46 billion from $9.04 billion in the prior year quarter. Sixteen analysts had consensus revenue estimate of $9.36 billion for the quarter.
Abbott raised its full-year 2012 ongoing earnings-per-share guidance to a range of $5.00 to $5.10 from the prior outlook of $4.95 to $5.05. Analysts expect the company to report earnings of $5.01 per share for fiscal 2012.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.